Rchr
J-GLOBAL ID：201401047838530502
Update date: Nov. 05, 2024
Otsuka Atsushi
オオツカ アツシ | Otsuka Atsushi
Affiliation and department：
Research field (1)：
Dermatology
Research keywords (3)：
melanoma
, atopic dermatitis
, allergy
Research theme for competitive and other funds (3)：
- 2020 - 2023 皮膚アレルギー疾患におけるシュワン細胞の病態関与
- 2017 - 2020 Pathological involvement of the neuroimmune cycle in skin allergic diseases
- 2010 - 2011 皮膚免疫における肥満細胞の役割
Papers (262)：
-
Yuichiro Tsunemi, Atsushi Otsuka, Yusuke Nonaka. Patient-physician perception gaps in setting treatment goals and communication including shared decision making: Results from the survey illuminating dialogues and insights in onychomycosis management (IDIOM survey). The Journal of Dermatology. 2024
-
Atsushi Otsuka, Chaochen Wang, Hitoe Torisu-Itakura, Takashi Matsuo, Yoshitaka Isaka, Peter Anderson, James Piercy, Jenny Austin, Simran Marwaha, Akio Tanaka. Patient and family burden in pediatric atopic dermatitis and its treatment pattern in Japan. International Journal of Dermatology. 2024
-
Yuichiro Tsunemi, Atsushi Otsuka, Yusuke Nonaka. Clinical inertia in onychomycosis treatment: results from the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) survey. The Journal of Dermatology. 2024
-
Taku Fujimura, Koji Yoshino, Hiroshi Kato, Satoshi Fukushima, Shoichiro Ishizuki, Atsushi Otsuka, Shigeto Matsushita, Ryo Amagai, Yusuke Muto, Emi Yamazaki, et al. Phase II, multicenter study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-PD-1 antibody-refractory malignant melanoma: TM5614-MM trial. The British journal of dermatology. 2024
-
Yuichiro Tsunemi, Atsushi Otsuka, Yusuke Nonaka. Receipt survey of prescription continuation rates for patients with onychomycosis and web-based survey of dermatologists on prescribing policies for onychomycosis therapeutics. The Journal of Dermatology. 2024
ｍore...
MISC (88)：
-
鈴木さつき, 臼居駿也, 西垣綾子, 中嶋千紗, 柳原茂人, 伊谷善仁, 大塚篤司, 後藤啓介, 三浦圭子. 頭部血管肉腫と鑑別を要した類上皮血管腫の1例. 日本皮膚科学会雑誌. 2023. 133. 3
-
中村泰大, 並川健二郎, 木庭幸子, 加藤裕史, 山崎修, 吉川周佐, 前川武雄, 竹之内辰也, 松下茂人, 中井康雄, et al. 進行期末端黒子型黒色腫に対する抗PD-1抗体治療増悪後二次治療の有効性-JAMP neo study副次解析. 西日本皮膚科. 2022. 84. 6
-
森龍彦, 並川健二郎, 木庭幸子, 加藤裕史, 山崎修, 吉川周佐, 前川武雄, 竹之内辰也, 松下茂人, 中井康雄, et al. 末端黒子型黒色腫に対するPD1抗体治療増悪後二次治療の有効性:JAMP-neo study副次解析. 日本癌治療学会学術集会(Web). 2022. 60th
-
廣田菜々子, 鈴木緑, 加藤麻衣子, 柳原茂人, 遠藤英樹, 大磯直毅, 川田暁, 大塚篤司, 田中薫, 藤田岳. A Case of Steven-Johnson Syndrome Induced by Nivolumab. 皮膚の科学. 2022. 21. 1
-
Hiroka Tomiyasu, Takaya Komori, Yoshihiro Ishida, Atsushi Otsuka, Kenji Kabashima. Eosinophilic gastroenteritis in a melanoma patient treated with nivolumab. Journal of Dermatology. 2021. 48. 10. E486-E487
ｍore...
Professional career (1)：
Return to Previous Page
